- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Sichuan Cancer Hospital & Institute
I alt 3928 resultater
-
Jiangsu Cancer Institute & HospitalAfsluttetNasopharyngealt karcinomKina
-
Jiangsu Cancer Institute & HospitalAfsluttetNasopharyngealt karcinomKina
-
Jiangsu Cancer Institute & HospitalIkke rekrutterer endnuStadie IVA Nasopharyngeal CarcinomKina
-
Jiangsu Cancer Institute & HospitalIkke rekrutterer endnu
-
Jiangsu Cancer Institute & HospitalRekrutteringLokalt avanceret esophageal carcinomKina
-
Jiangsu Cancer Institute & HospitalRekrutteringAvanceret tyktarmskræftKina
-
Jiangsu Cancer Institute & HospitalAktiv, ikke rekrutterendeLungekræft, ikke-småcelletKina
-
Jiangsu Cancer Institute & HospitalUkendtDiffust stort B-cellet lymfom (DLBCL)Kina
-
Peking Union Medical College HospitalZhejiang Cancer Hospital; Xiangya Hospital of Central South University; Sun... og andre samarbejdspartnereRekrutteringLivmoderhalskræft | Bivirkning til strålebehandling | Strålebehandling; KomplikationerKina
-
Southwest Hospital, ChinaXiangya Hospital of Central South University; Henan Cancer Hospital; Hunan... og andre samarbejdspartnereUkendt
-
Cancer Institute and Hospital, Chinese Academy...The First Affiliated Hospital with Nanjing Medical University; Fujian Cancer... og andre samarbejdspartnereRekrutteringEsophageale neoplasmerKina
-
Sichuan Cancer Hospital and Research InstituteThe First Affiliated Hospital with Nanjing Medical University; Peking University... og andre samarbejdspartnereIkke rekrutterer endnu
-
Jiangsu Famous Medical Technology Co., Ltd.Zhejiang Cancer Hospital; Shanxi Province Cancer Hospital; Jiangsu Province... og andre samarbejdspartnereIkke rekrutterer endnuKolorektal cancer | Kolorektalt adenom
-
Cancer Institute and Hospital, Chinese Academy...Henan Cancer Hospital; Beijing Hospital; Jiangsu Cancer Institute & Hospital og andre samarbejdspartnereAfsluttet
-
Massachusetts General HospitalM.D. Anderson Cancer Center; National Cancer Institute (NCI)Aktiv, ikke rekrutterendeKordoma af Sacrum | Chordoma af Rygsøjlen | Chordom af Skallebasis | Chondrosarkom i rygsøjlen | Chondrosarcoma of the SacrumForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Massachusetts General HospitalAktiv, ikke rekrutterendeSpiserørskræftForenede Stater
-
Massachusetts General HospitalM.D. Anderson Cancer Center; National Cancer Institute (NCI)Aktiv, ikke rekrutterendeHjerne svulst | Medulloblastom | PineoblastomForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Massachusetts General HospitalAfsluttetLungekræftForenede Stater
-
Affiliated Hospital of Jiangnan UniversityWest China Hospital; Hunan Cancer Hospital; Shenzhen Second People's Hospital og andre samarbejdspartnereRekrutteringPleural effusion, ondartetKina
-
Massachusetts General HospitalM.D. Anderson Cancer Center; National Cancer Institute (NCI); Dana-Farber... og andre samarbejdspartnereRekruttering
-
Peking University Cancer Hospital & InstituteBeijing Nanjiao Cancer HospitalRekruttering
-
Sichuan Cancer Hospital and Research InstituteFirst Affiliated Hospital Xi'an Jiaotong University; General Hospital of... og andre samarbejdspartnereUkendtLokalt avanceret esophageal pladecellecarcinomKina
-
Zhejiang Cancer HospitalFudan University; Cancer Institute and Hospital, Chinese Academy of Medical... og andre samarbejdspartnereAfsluttetStadie III ikke-småcellet lungekræftKina
-
Peking University Cancer Hospital & InstituteRekrutteringB7H3 | CD276 Affibody | PET/CT billeddannelseKina
-
Shandong Cancer Hospital and InstituteRekruttering
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuNeoplasma i maven | Lymfeknudemetastase | RADIONUKLID BILLEDGANG
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuMelanom | Metastatisk melanom | Slimhinde melanomKina
-
Shandong Cancer Hospital and InstituteRekrutteringSpiserørskræft | Epigallocatechin Gallate | Dysfagi, esophagealKina
-
Peking University Cancer Hospital & InstituteRekrutteringRecidiverende/refraktær B-celle non-Hodgkin lymfomKina
-
Shandong Cancer Hospital and InstituteRekrutteringNeoadjuverende terapi | Resecerbart ikke-småcellet lungekarcinom | IMMUNOTERAPI | Biomarkører / BlodKina
-
Peking University Cancer Hospital & InstituteRekrutteringKræft i fordøjelsessystemetKina
-
Shandong Cancer Hospital and InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuMetastatisk kastrationsresistent prostatakræft
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringFase 2-undersøgelse af SBRT Plus Tislelizumab og Regorafenib i uoperabelt eller oligometastatisk HCCIkke-operabelt hepatocellulært karcinom | Oligometastatisk sygdomKina
-
Peking University Cancer Hospital & InstituteRekrutteringKolorektal cancer | LungekræftKina
-
Peking University Cancer Hospital & InstituteRekrutteringIkke-småcellet lungekræft | Konsoliderende immunterapi | Strålebehandling eller sekventiel kemoradiationKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuCOVID-19 | Kirurgi-komplikationerKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuBlødt vævssarkom
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringMelanom | Temozolomid | Apatinib | Camrelizumab | Akralt melanom | Neoadjuvans | Patologisk responsKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekrutteringAvanceret melanomKina
-
Shandong Cancer Hospital and InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekrutteringMelanom | Lungekræft | PD-L1 | PET/CTKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekruttering